Are you responsible for overseeing and improving the quality of care within your hospital or health system? Then you’ve probably heard about the two new quality measures involving glycemic management that CMS announced this summer. If you haven’t yet, we have plenty of resources available to help get you caught up, including a high-level overview and an on-demand CMS session from Glytec’s inaugural industry event, “Time to Target: Uniting Around Patient Safety.”
If you’re well-versed in the newly-announced electronic clinical quality measures (eCQMs) already, it’s time to take a deeper dive and start planning to ensure your organization stays ahead of the pack once CMS begins collecting – and more importantly – publishing performance data around glycemic rates. This is exactly why Dr. Danielle Scheurer and I recently connected during a recent webinar hosted by Becker’s Healthcare to discuss how to prepare for these measures.
Dr. Scheurer is a practicing Hospitalist Physician and the Chief Quality Officer for the Medical University of South Carolina hospital (MUSC). During our conversation, she shared how MUSC has used other eCQMs to drive practice change and provide a consistent metric of performance year over year. She also offered a template for institutions to implement or expand on glycemic management quality programs to strategically leverage the new eCQMs to improve patient safety and quality of care in the hospital.
Dr. Scheurer’s 5 tips for quality teams:
While CMS hasn’t published an exact timeline for implementing these measures, people familiar with CMS’s previous eCQM roll-outs predict that data will start being collected in January 2023. As we know, quality improvement projects take time. Hospital leaders need to start taking action today to improve their data before the eCQMs are live.
The timeline below highlights key dates for the new rules:
In the end, collecting and publishing this data will set national benchmarks that will help everyone – payers, providers and the public – understand what good glycemic management looks like, and which hospitals we should learn from in order to set the new standard of care. By introducing transparency that can be used to compare hospitals on how they manage patient safety, this measure will also incentivize change and solutions for inpatient glycemia care. Hospitals can’t improve what they don’t measure, and CMS’s focus will help hospital leaders prioritize efforts to attain optimal glycemic management and implement solutions that will improve quality and decrease costs while personalizing care for patients.
It’s clear from Dr. Scheurer’s feedback that successful glycemic management programs are made up of great people, innovative technology and a streamlined process. These three ingredients will be essential for health systems as they embark on increasing their visibility into the new eCQM metrics and improving inpatient glycemic care.
MAR-0000738 Rev 1.0
©Copyright 2023 Glytec, LLC on behalf of Aseko, Inc. | Terms of Use | Legal Disclaimer | Privacy Policy | Contraindications, Warnings and Precautions
The eGlycemic Management System® is a modularized solution for glycemic management across the care continuum that includes Glucommander™. Glucommander™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.
Glucommander™ is only available for use in the United States.
This site is only intended for use in the United States.
Aseko is a registered trademark of Aseko, Inc.